Blue Earth Therapeutics

Blue Earth Therapeutics is a clinical-stage company developing next-generation targeted radiotherapeutics for cancer treatment. Their focus is on PSMA-targeted radioligand therapies for prostate cancer, aiming to improve patient outcomes by delivering high radiation doses to tumors while preserving normal organ safety. The company is advancing its clinical-stage PSMA-targeted radioligand therapies.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $76.5M

Date: 30-Oct-2024

Investors: Soleus Capital, Sands Capital Management, Bracco Imaging SpA, Woodline Partners, PBM Capital

Markets: Biotechnology, Oncology, Radiopharmaceuticals

HQ: Oxford, Oxfordshire, United Kingdom

Founded: 2021

Website: https://www.blueearththerapeutics.com

LinkedIn: https://uk.linkedin.com/company/blue-earth-therapeutics

Twitter:

Instagram: